Filing Details

Accession Number:
0000899243-21-012766
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2021-03-19 17:05:10
Reporting Period:
2021-03-15
Accepted Time:
2021-03-19 17:05:10
Original Submission Date:
2021-03-17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501134 Invitae Corp NVTA Services-Medical Laboratories (8071) 271701898
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1689575 Katherine Stueland C/O Invitae Corporation
1400 16Th Street
San Francisco CA 94103
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-03-15 5,781 $42.90 209,764 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The purpose of this amendment is to correct the transaction code that was incorrectly reported on the reporting person's original Form 4.
  2. Represents the sale of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.
  3. Represents a weighted average sale price. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold.
  4. Includes an aggregate of 105,817 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.